Nanotechnology
is defined as the art and science of assembling
objects on a scale under 100 nanometers in
length.
The concept of
nanotechnology was first propounded by Nobel Laureate Richard Feynman in 1959.
Use in anesthesia: Functionalities
can be added to nanomaterials by interfacing them with biological molecules. Once injected, the
nanorobots would freely float inside the body, detecting and attaching to very
specific receptors, for example, gamma-aminobutyric acid (GABA), opioid and
neuromuscular junction receptors.Thus, they would perform a highly focussed
task:
· In
the brain, by attaching to GABA receptors they produce loss of consciousness
and amnesia,
· At
the neuromuscular junction they provide full muscle relaxation giving good
intubating conditions
· Activation
of opioid receptors causing profound analgesia.
The
desirable characteristics of a nanorobot are an optimal size of 0.5–3 μm to
enable passage through capillaries, non-agglutinability with blood cells and
recognisability of very specific receptors only.
POSSIBLE
ADVANCES OF NANOTECHNOLOGY IN ANAESTHESIOLOGY
1. General
anaesthesia
- Administration, regulation and monitoring of GAà Neuroelectronic interfacing will allow nanodevices to be linked to the human nervous system. This would permit control and detection of nerve impulses to be interpreted by an external computerà computer-controlled GA (researchers from Canary Islands have developed a technique for automatically controlling anaesthesia)
- Effects of coexisting diseases and injuries impairing anaesthesia could be overcome through using neuroelectronic interface
2. Regional anaesthesia
Bupivacaine
overdoseà antidote of
bupivacaine with nanotechnology. There is a formation of pi–pi complexes between
bupivacaine and a pi-electron–rich injectable nanoparticle. This complex is
devoid of the clinical effects of bupivacaineàrapid and easy
management of high spinal anesthesia
3. Local anaesthesia
Rapid
local transdermal anaestheticà lidocaine-loaded (PCL–PEG–PCL) nanoparticles.
Tested
in ratsàsuperior in terms of
onset of anaesthesia and efficacy. Further research awaited.
4. Future
advances in superspecialities of anaesthesiology
- Chronic Pain and palliative careà saxitoxin, a potent anaesthetic, bundled with liposomes. This is a slow- release formulation can produce a nerve block lasting from days to weeks and even months, at the same time being nontoxic to the nerves or the surrounding tissue.
- Critical care:
- Vasculoidsà circulatory system in the form of artificial blood which transports resources around the body without the need for a heart or other pump àserves as a complete replacement for natural blood.
- Respirocytesà hypothetical, microscopic, artificial red blood cells that can emulate the function of natural RBC with 200 times the efficiency. Respirocytes would also speed up weaning from ventilators.
- Clottocytesà artificial mechanical plateletsà The response time of a clottocyte would be on the order of 100-1000 times quicker than nature's platelets, achieving complete hemostasis in as short as one second.
- Nanoatropine: In Organophosphorus poisoningà inhaled atropine (dry powder which can be inhaled quickly by the time other therapeutic options are arranged).
- Microbivoresàmimic white cells and perform phagocytosis of specific bacteria, viruses or fungi. Control of drug resistant infections.
Advantages of Nanorobots:
- As the
nanorobots are nonbiological entities and do not generate any harmful
activities, there shall be no side effects
- They
are useful in both general as well as regional anaesthesia
- Being
highly specific and target oriented, they reduce the anaesthesia-associated
mortality and morbidity
- Since
they reach specific receptors, lesser drug dosage is required, limiting
the side effects
- As they
bind the terminal receptors, there shall be no peaks and troughs in
effect.
Disadvantage: high cost and
complicated fabrication
Further Reading:
1.
|
Drexler KE.
Nanosystems: Molecular Machinery, Manufacturing, and Computation. 1992..
|
2.
|
Kaira L, Singh R. Nanotechnology
: the new era of technology. Nitte University Journal of Health Science. 2012
December ; 2(4).
|
3.
|
Agarwal A. The future
of anaesthesiology. IJA. 2012; 56(6): p. 524-528.
|
4.
|
Iliades C, Jon N.
everydayhealth.com. [Online]. [cited 2015 may. Available from: http://www.everydayhealth.com/pain-management/nanoparticles-the-high-tech-way-to-treat-pain.aspx.
|
No comments:
Post a Comment